Market Cap $ M	71,819.89
Enterprise Value $ M	140,843.01
P/E(ttm)	10.05
PE Ratio without NRI	8.77
Forward PE Ratio	7.98
Price/Book	0.97
Price/Sales	0.20
Price/Free Cash Flow	8.95
Price/Owner Earnings	9.56
Payout Ratio %	0.38

Revenue (TTM) $ M	360,935.00
EPS (TTM) $	5.69
Beneish M-Score	-2.25
10-y EBITDA Growth Rate %	3.90
5-y EBITDA Growth Rate %	9.00
y-y EBITDA Growth Rate %	43.70
EV-to-EBIT	11.13
EV-to-EBITDA	8.21
PEG	0.97
Shares Outstanding M	1,255.37

Net Margin (%)	2.03
Operating Margin %	3.62
Pre-tax Margin (%)	2.74
Quick Ratio	0.61
Current Ratio	0.81
ROA % (ttm)	2.95
ROE % (ttm)	9.92
ROIC % (ttm)	5.14
Dividend Yield %	4.43
Altman Z-Score	2.13

Piotroski F-Score	7.00
Positive ROA	Y
Positive CFROA	Y
Higher ROA y-y	Y
Cash flow > Earnings	Y
Lower Leverage y-y	Y
Higher Current Ratio y-y	N
Less Shares Outstanding y-y	Y
Gross Margin Increase y-y	N
Higher Asset Turnover y-y	Y

CVS Number of Guru Trades

CVS Volume of Guru Trades

Gurus Latest Trades with NYSE:CVS

No Available Data

NYSE:CVS is held by these investors

Guru
Dodge & Cox
HOTCHKIS & WILEY
Richard Pzena
T Rowe Price Equity Income Fund
Barrow, Hanley, Mewhinney & Strauss
Bill Nygren
Charles Brandes
John Rogers
Tom Gayner
Mario Gabelli
Chris Davis
Robert Olstein
Joel Greenblatt
Ken Fisher
Prem Watsa

Guru	Portfolio Date	Current Shares	% of Shares outstanding	% of Total Assets Managed	Comment
You need a Premium membership or above to view this section. Take a 7-Day Free Trial
Dodge & Cox	2024-03-31	41,012,543	3.27	1.90%	Add 34.85%
HOTCHKIS & WILEY	2024-03-31	6,647,790	0.53	1.77%	Reduce -0.72%
Richard Pzena	2024-03-31	5,553,457	0.44	1.52%	Add 573.76%
T Rowe Price Equity Income Fund	2024-03-31	2,590,000	0.21	1.15%
Barrow, Hanley, Mewhinney & Strauss	2024-03-31	2,582,627	0.21	0.69%	Reduce -19.19%
Bill Nygren	2023-12-31	2,544,000	0.20	1.10%	Add 8.53%
Charles Brandes	2024-03-31	1,526,115	0.12	1.57%	Add 10.31%
John Rogers	2024-03-31	606,609	0.05	0.48%	New holding
Tom Gayner	2024-03-31	332,000	0.03	0.26%
Mario Gabelli	2024-03-31	186,514	0.01	0.15%	Reduce -10.29%
Chris Davis	2024-03-31	172,743	0.01	0.08%	Reduce -16.31%
Robert Olstein	2024-03-31	129,000	0.01	1.68%	Reduce -9.15%
Joel Greenblatt	2024-03-31	104,116	0.01	0.13%	Reduce -16.41%
Ken Fisher	2024-03-31	71,100	0.01	0%	Add 4.77%
Prem Watsa	2024-03-31	15,000	0	0.10%

Total 15

CVS Health Corp Insider Transactions

No Available Data

News about NYSE:CVS

Total 0

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.